252 related articles for article (PubMed ID: 27431826)
1. Development of Optimized AAV Serotype Vectors for High-Efficiency Transduction at Further Reduced Doses.
Ling C; Li B; Ma W; Srivastava A
Hum Gene Ther Methods; 2016 Aug; 27(4):143-9. PubMed ID: 27431826
[TBL] [Abstract][Full Text] [Related]
2. Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses.
Zhong L; Li B; Mah CS; Govindasamy L; Agbandje-McKenna M; Cooper M; Herzog RW; Zolotukhin I; Warrington KH; Weigel-Van Aken KA; Hobbs JA; Zolotukhin S; Muzyczka N; Srivastava A
Proc Natl Acad Sci U S A; 2008 Jun; 105(22):7827-32. PubMed ID: 18511559
[TBL] [Abstract][Full Text] [Related]
3. Chimeric Capsid Proteins Impact Transduction Efficiency of Haploid Adeno-Associated Virus Vectors.
Chai Z; Zhang X; Dobbins AL; Frost EA; Samulski RJ; Li C
Viruses; 2019 Dec; 11(12):. PubMed ID: 31835440
[TBL] [Abstract][Full Text] [Related]
4. Bioengineering of AAV2 capsid at specific serine, threonine, or lysine residues improves its transduction efficiency in vitro and in vivo.
Gabriel N; Hareendran S; Sen D; Gadkari RA; Sudha G; Selot R; Hussain M; Dhaksnamoorthy R; Samuel R; Srinivasan N; Srivastava A; Jayandharan GR
Hum Gene Ther Methods; 2013 Apr; 24(2):80-93. PubMed ID: 23379478
[TBL] [Abstract][Full Text] [Related]
5. Targeted modifications in adeno-associated virus serotype 8 capsid improves its hepatic gene transfer efficiency in vivo.
Sen D; Gadkari RA; Sudha G; Gabriel N; Kumar YS; Selot R; Samuel R; Rajalingam S; Ramya V; Nair SC; Srinivasan N; Srivastava A; Jayandharan GR
Hum Gene Ther Methods; 2013 Apr; 24(2):104-16. PubMed ID: 23442071
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine models.
Markusic DM; Nichols TC; Merricks EP; Palaschak B; Zolotukhin I; Marsic D; Zolotukhin S; Srivastava A; Herzog RW
J Transl Med; 2017 May; 15(1):94. PubMed ID: 28460646
[TBL] [Abstract][Full Text] [Related]
7. Optimized adeno-associated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses.
Jayandharan GR; Zhong L; Sack BK; Rivers AE; Li M; Li B; Herzog RW; Srivastava A
Hum Gene Ther; 2010 Mar; 21(3):271-83. PubMed ID: 19788390
[TBL] [Abstract][Full Text] [Related]
8. Development of novel AAV serotype 6 based vectors with selective tropism for human cancer cells.
Sayroo R; Nolasco D; Yin Z; Colon-Cortes Y; Pandya M; Ling C; Aslanidi G
Gene Ther; 2016 Jan; 23(1):18-25. PubMed ID: 26270885
[TBL] [Abstract][Full Text] [Related]
9. Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors.
Kay CN; Ryals RC; Aslanidi GV; Min SH; Ruan Q; Sun J; Dyka FM; Kasuga D; Ayala AE; Van Vliet K; Agbandje-McKenna M; Hauswirth WW; Boye SL; Boye SE
PLoS One; 2013; 8(4):e62097. PubMed ID: 23637972
[TBL] [Abstract][Full Text] [Related]
10. Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells.
Cheng B; Ling C; Dai Y; Lu Y; Glushakova LG; Gee SW; McGoogan KE; Aslanidi GV; Park M; Stacpoole PW; Siemann D; Liu C; Srivastava A; Ling C
Gene Ther; 2012 Apr; 19(4):375-84. PubMed ID: 21776025
[TBL] [Abstract][Full Text] [Related]
11. Adeno-associated virus type 2-mediated gene transfer: role of cellular T-cell protein tyrosine phosphatase in transgene expression in established cell lines in vitro and transgenic mice in vivo.
Qing K; Li W; Zhong L; Tan M; Hansen J; Weigel-Kelley KA; Chen L; Yoder MC; Srivastava A
J Virol; 2003 Feb; 77(4):2741-6. PubMed ID: 12552015
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expression.
Zhong L; Li B; Jayandharan G; Mah CS; Govindasamy L; Agbandje-McKenna M; Herzog RW; Weigel-Van Aken KA; Hobbs JA; Zolotukhin S; Muzyczka N; Srivastava A
Virology; 2008 Nov; 381(2):194-202. PubMed ID: 18834608
[TBL] [Abstract][Full Text] [Related]
13. Structural and Biophysical Analysis of Adeno-Associated Virus Serotype 2 Capsid Assembly Variants.
Bennett A; Gargas J; Kansol A; Lewis J; Hsi J; Hull J; Mietzsch M; Tartaglia L; Muzyczka N; Bhattacharya N; Chipman P; Agbandje-McKenna M; McKenna R
J Virol; 2023 Jul; 97(7):e0177222. PubMed ID: 37310260
[TBL] [Abstract][Full Text] [Related]
14. Efficient Gene Delivery and Expression in Pancreas and Pancreatic Tumors by Capsid-Optimized AAV8 Vectors.
Chen M; Maeng K; Nawab A; Francois RA; Bray JK; Reinhard MK; Boye SL; Hauswirth WW; Kaye FJ; Aslanidi G; Srivastava A; Zajac-Kaye M
Hum Gene Ther Methods; 2017 Feb; 28(1):49-59. PubMed ID: 28125909
[TBL] [Abstract][Full Text] [Related]
15. Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.
Rutledge EA; Halbert CL; Russell DW
J Virol; 1998 Jan; 72(1):309-19. PubMed ID: 9420229
[TBL] [Abstract][Full Text] [Related]
16. Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo.
Song L; Kauss MA; Kopin E; Chandra M; Ul-Hasan T; Miller E; Jayandharan GR; Rivers AE; Aslanidi GV; Ling C; Li B; Ma W; Li X; Andino LM; Zhong L; Tarantal AF; Yoder MC; Wong KK; Tan M; Chatterjee S; Srivastava A
Cytotherapy; 2013 Aug; 15(8):986-98. PubMed ID: 23830234
[TBL] [Abstract][Full Text] [Related]
17. Genetic modification of adeno-associated viral vector type 2 capsid enhances gene transfer efficiency in polarized human airway epithelial cells.
White AF; Mazur M; Sorscher EJ; Zinn KR; Ponnazhagan S
Hum Gene Ther; 2008 Dec; 19(12):1407-14. PubMed ID: 18778196
[TBL] [Abstract][Full Text] [Related]
18. Application of polyploid adeno-associated virus vectors for transduction enhancement and neutralizing antibody evasion.
Chai Z; Sun J; Rigsbee KM; Wang M; Samulski RJ; Li C
J Control Release; 2017 Sep; 262():348-356. PubMed ID: 28789965
[TBL] [Abstract][Full Text] [Related]
19. Impact of capsid modifications by selected peptide ligands on recombinant adeno-associated virus serotype 2-mediated gene transduction.
Naumer M; Popa-Wagner R; Kleinschmidt JA
J Gen Virol; 2012 Oct; 93(Pt 10):2131-2141. PubMed ID: 22764318
[TBL] [Abstract][Full Text] [Related]
20. Capsid Engineering Overcomes Barriers Toward Adeno-Associated Virus Vector-Mediated Transduction of Endothelial Cells.
Zhang L; Rossi A; Lange L; Meumann N; Koitzsch U; Christie K; Nesbit MA; Moore CBT; Hacker UT; Morgan M; Hoffmann D; Zengel J; Carette JE; Schambach A; Salvetti A; Odenthal M; Büning H
Hum Gene Ther; 2019 Oct; 30(10):1284-1296. PubMed ID: 31407607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
